Cargando…
Clinical use of amyloid-positron emission tomography neuroimaging: Practical and bioethical considerations
Until recently, estimation of β-amyloid plaque density as a key element for identifying Alzheimer's disease (AD) pathology as the cause of cognitive impairment was only possible at autopsy. Now with amyloid-positron emission tomography (amyloid-PET) neuroimaging, this AD hallmark can be detecte...
Autores principales: | Witte, Michael M., Foster, Norman L., Fleisher, Adam S., Williams, Monique M., Quaid, Kimberly, Wasserman, Michael, Hunt, Gail, Roberts, J. Scott, Rabinovici, Gil D., Levenson, James L., Hake, Ann Marie, Hunter, Craig A., Van Campen, Luann E., Pontecorvo, Michael J., Hochstetler, Helen M., Tabas, Linda B., Trzepacz, Paula T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4878065/ https://www.ncbi.nlm.nih.gov/pubmed/27239516 http://dx.doi.org/10.1016/j.dadm.2015.06.006 |
Ejemplares similares
-
Tutorials in population neuroimaging: Using epidemiology in neuroimaging research
por: Godina, Sara, et al.
Publicado: (2022) -
Neuroimaging referral for dementia diagnosis: The specialist's perspective in Ireland
por: Ciblis, Aurelia S., et al.
Publicado: (2015) -
Multimodal neuroimaging study of cerebrovascular disease, amyloid deposition, and neurodegeneration in Alzheimer's disease progression
por: Lao, Patrick J., et al.
Publicado: (2018) -
Machine learning of neuroimaging for assisted diagnosis of cognitive impairment and dementia: A systematic review
por: Pellegrini, Enrico, et al.
Publicado: (2018) -
Characteristic Neuroimaging Findings in β-propeller Protein-associated Neurodegeneration
por: Larsh, Travis
Publicado: (2021)